0 likes | 5 Views
The global Analgesics Market size is expected to reach USD 56.86 million, at a CAGR of 4.90% by 2030.
E N D
Analgesics Market The global Analgesics Market size is expected to reach USD 56.86 million at a CAGR of 4.90% during the forecast by 2030 Next Move Strategy Consulting
Agenda • Market Overview • Market Segmentation • Regional Analysis • Key Market Players • Key Highlights Next Move Strategy Consulting
Market Overview • The term ‘analgesics’ refers to a class of drugs that are designed to relieve pain without causing the loss of consciousness. These medicines are used as pain-relieving agents to reduce different types of pain such as headaches and arthritis. • The increasing prevalence of chronic diseases such as heart diseases, stroke, chronic obstructive pulmonary disease, asthma, and diabetes are causing untimely deaths in nations with low to medium incomes. • Factors such as the surging demand for exact and appropriate laparoscopic medical procedures, rising need for surgeries for the geriatric population, and growing instances of injury wounds have all contributed to the increased use of analgesics. • Medical device manufacturers are facing an exceptionally unpredictable regulatory environment. Next Move Strategy Consulting
Market Segmentation • By Type • Non-Opioids • Opioids • By Route of Administration • Oral Route • Intravenous Route • Rectal Route • Transdermal Route • Topical Route Next Move Strategy Consulting
Regional Analysis • North America • The U.S. • Canada • Mexico • Asia-Pacific • China • India • Japan • South Korea • Australia • Rest of Asia-Pacific • RoW • UAE • Saudi Arabia • South Africa • Brazil • Remaining Countries • Europe • The UK • Germany • France • Italy • Spain • Denmark • Netherlands • Finland • Sweden • Norway • Russia Next Move Strategy Consulting
Key Market Players • Abbott Laboratories • Bayer AG • Glaxosmithkline plc • Johnson and Johnson • Pfizer, Inc • Novartis AG • Teva Pharmaceuticals • Sanofi SA • ABBVIE INC • Sun Pharmaceutical Industries, Inc Next Move Strategy Consulting
Key Highlights • The global analgesics market is characterized by robust growth, driven by increasing pain prevalence and rising awareness about pain management. Key segments include non-opioid analgesics, such as acetaminophen and NSAIDs, and opioid analgesics, which remain essential despite growing concerns about addiction. The non-opioid segment is expanding due to its lower addiction risks and efficacy in managing mild to moderate pain. • Geographically, North America leads the market, supported by advanced healthcare infrastructure and high incidence of chronic pain conditions. However, the Asia-Pacific region is experiencing rapid growth, fueled by rising healthcare access and a large patient population. • Key trends include the development of innovative pain management solutions, such as extended-release formulations and combination drugs, which offer enhanced efficacy and reduced side effects. Additionally, there's a growing shift towards personalized medicine, driven by advancements in genomics and drug development. Next Move Strategy Consulting
THANK YOU Follow us Next Move Strategy Consulting www.nextmsc.com info@nextmsc.com +1-217-650-7991 Access Full Report - https://www.nextmsc.com/report/analgesics-market Next Move Strategy Consulting